Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA)

The summary for the Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Substance Abuse and Mental Health Services Adminis, which is the U.S. government agency offering this grant.
Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA): The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2017 Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those with the most dramatic increases for heroin and opioids, as identified by SAMHSA's Treatment Episode Data Set (TEDS): 2007 – 2014. The desired outcomes include: 1) an increase in the number of admissions for MAT; 2) an increase in the number of clients receiving integrated care/treatment; 3) a decrease in illicit opioid drug use at six-month follow-up; and 4) a decrease in the use of prescription opioids in a non-prescribed manner at six-month follow-up. For the purpose of this FOA, integrated care/treatment is defined as the organized delivery and/or coordination of medical (including the use of Food and Drug Administration (FDA)-approved drugs [buprenorphine, methadone, extended release injectable naltrexone] for addiction), behavioral, social, peer, and other recovery support services provided to individual patients who have multiple healthcare needs in order to produce better overall health outcomes. MAT is defined as the use of FDA-approved opioid agonist medications (e.g., methadone, buprenorphine products, including buprenorphine/naloxone combination formulations and buprenorphine mono-product formulations) for the maintenance treatment of opioid use disorder and opioid antagonist medication (e.g., extended-release) in combination with behavioral therapies to prevent relapse to opioid use. MAT includes screening, assessment (which includes determination of severity of opioid use disorder, including presence of physical dependence and appropriateness for MAT), and case management. MAT is to be provided in combination with comprehensive opioid use disorder treatment, including but not limited to: counseling, behavioral therapies, other clinically appropriate services in order for individuals to achieve and maintain abstinence from all opioids and heroin, and, when needed, pharmacotherapy for co-occurring alcohol use disorder. MAT is to be provided in a clinically driven, person-centered, and individualized setting.
Federal Grant Title: Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA)
Federal Agency Name: Substance Abuse and Mental Health Services Adminis (HHS-SAMHS-SAMHSA)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: TI-17-017
Type of Funding: Grant
CFDA Numbers: 93.243
CFDA Descriptions: Information not provided
Current Application Deadline: July 31st, 2017
Original Application Deadline: July 31st, 2017
Posted Date: May 31st, 2017
Creation Date: May 31st, 2017
Archive Date: August 30th, 2017
Total Program Funding: $28,000,000
Maximum Federal Grant Award: $2,000,000
Minimum Federal Grant Award: $0
Expected Number of Awards: 5
Cost Sharing or Matching: No
Last Updated: May 31st, 2017
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
As the 2017 Omnibus requires, eligibility is limited to the states with the highest rates of admissions, including those that have demonstrated a dramatic increase in admissions for the treatment of opioid use disorder. See Appendix E for a list of eligible states. The application must be submitted by the Single State Agency (SSA) for Substance Abuse within the state. FY 2015 MAT-PDOA grantees funded under announcement TI-15-007 and FY 2016 MAT-PDOA grantees funded under announcement TI-16-014 are not eligible to apply for this program.
Link to Full Grant Announcement
Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA)
Grant Announcement Contact
Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1412
[email protected]
Similar Government Grants
National Child Traumatic Stress Initiative - Category III - Community Treatment and Servic...
National Child Traumatic Stress Initiative - Category II
Recovery Community Services Program
Grants for the Benefit of Homeless Individuals
Expansion of Practitioner Education
Grants to Expand Substance Abuse Treatment Capacity in Targeted Areas of Need
State Adolescent Substance Abuse Treatment Coordination
Circles of Care III: Tribal Infrastructure Grants for Transforming Behavioral Health Servi...
More Grants from the Substance Abuse and Mental Health Services Adminis
National Child Traumatic Stress Initiative - Category III - Community Treatment and Servic...
National Child Traumatic Stress Initiative - Category II
Recovery Community Services Program

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com